Miller Aine — SEC insider filings
SEC reporting owner CIK 2012524. 15 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-22 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | SVP, DEV & HEAD OF IRE OFFICE | 15 | — | — | 18 |
Insider filings — Miller Aine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Disposition to issuer (D): 93,108 · Disposition to issuer (D): 96,718 · Disposition to issuer (D): 37,500 (derivative) | EDGAR |
| 2026-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 6,258 @ $16.95 | EDGAR |
| 2026-06-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 18,750 @ $0 | EDGAR |
| 2026-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 6,827 @ $16.55 | EDGAR |
| 2026-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 16,851 @ $19.66 | EDGAR |
| 2025-11-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 6,989 @ $17.90 | EDGAR |
| 2025-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 6,989 @ $13.39 | EDGAR |
| 2025-05-21 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 10,430 @ $0 · Tax withholding (F): 9,701 @ $9.45 | EDGAR |
| 2025-03-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,295 @ $9.66 | EDGAR |
| 2024-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 10,076 @ $9.97 | EDGAR |
| 2024-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 5,201 @ $8.22 | EDGAR |
| 2024-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 5,201 @ $9.10 | EDGAR |
| 2024-04-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 37,500 @ $0 | EDGAR |
| 2024-02-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,782 @ $8.92 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2012524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs